Prof. Pohl Milón
Centro de Investigación e Innovación Universidad Peruana
de Ciencias Aplicadas UPC
Lima, Perú
Synthetic molecules for biosensing or inhibiting pathogenic microorganisms
Katherin Peñaranda2, José Alberto Nakamoto1, Diego F. Joseph1, Ana Elena Sanchez1, and Pohl Milón1,2,*
(1) Centro de Investigación e Innovación, Universidad Peruana de Ciencias Aplicadas-UPC, Lima, Perú
(2) Research and Innovation Division, BDM, Lima, Peru ́
* Presenter: pmilon@upc.edu.pe
Pathogenic microorganisms are a common problem to human health, agriculture, and alimentary industries, among others, causing deaths and economic loses worldwide. The prompt detection and inhibition of infectious microorganisms save lives and allow tailored interventions to reduce financial impacts. Here, we use large genomic, transcriptomic, and proteomic data sets to identify novel biomarkers and therapeutic targets that are species-specific and absent in the host. On the other hand, we use the SELEX technology to develop aptamers for the specific recognition or inhibition of abundant and/or essential proteins from pathogenic microorganisms. Biochemical assays coupled to structural modeling allowed to characterize the interaction of aptamers against the HGMB1, a biomarker of Plasmodium falciparum, causing Malaria. Similarly, aptamers developed against an abundant protein of Trypanosoma Cruzi, causing Chagas disease, have been adapted for ELISA-like detection systems. Rapid kinetics, molecular modeling, and structural approximations show that aptamers against the bacterial translation initiation factor IF3 result in inhibiting initial steps of protein synthesis, i.e. aptamers as antibiotics. Altogether, aptamer applications as biosensing or therapeutic molecules will be discussed as attempts to tackle-down the negative impact that pathogenic microorganisms bring to societies.
Keywords: biosensor, biomarker, antibiotic, protein synthesis, FRET, rapid kinetics